advanced search

Welcome: Guest

log in

Diagnostics Market Research

Explore your competitors and realise your potential in the Diagnostics market. Our reports include information on Testing, Companion Markets, Imaging and In Vitro Diagnostics.

Stay up-to-date with new products added to this category
Title Date Price
Competitor Analysis: Coagulation Factors
Oct 2009 £450
Competitor Analysis VEGF and VEGF-R Agonists and Antagonists
Sep 2009 £540
UK Diagnostic Imaging Market Analysis and Forecasts to 2015
Sep 2009 £2,135
Advanced Digital Diagnostic Medical Imaging Equipment Market Analysis & Directions
Sep 2009 £1,540
U.S. DNA-Based Diagnostic Test and Equipment Market Analysis & Directions
Market Trends, New Product Trends, Technology Trends, Distribution Structure and 15 Notable Company Case Studies
Sep 2009 £1,880
Innovations in Medical Imaging
Technological Advances, Growth Opportunities and Future Market Outlook
Aug 2009 £2,340
Global Molecular Diagnostics Market
Opportunities & Future Forecast
Aug 2009 £610
Infectious Disease Diagnostic Markets
Aug 2009 £2,135
Coagulation Factors 2009
Target Pipeline and Corporate Benchmark Analysis
Aug 2009 £2,215
CEO 360 Degree Perspective - Global Clinical Diagnostics Industry
Aug 2009 £3,660
Diagnostic & Medical Laboratories in the US
IBISWorld Industry Report
Aug 2009 £395
Over-the-Counter Diagnostic Products World Markets
Aug 2009 £2,140
What Is Working in IVD
Successful Commercialization of New Products and Technologies
Jul 2009 £1,525
Strategic Analysis of U.S. Drugs of Abuse Laboratory Testing
Jul 2009 £3,660
Medical Ultrasound Systems Market Worldwide. 2009
Jul 2009 £1,520
Molecular Diagnostics Market: Trends and Opportunities
Jul 2009 £485
Medical Imaging Markets
Jun 2009 £2,105
The Top 40 Manufacturers Of Diagnostic Imaging Equipment In Europe
Jun 2009 £250
U.S. Market for Diagnostic Opthalmic Devices 2009
Jun 2009 £4,570
Point of Care Diagnostic Testing Sector Trends
Jun 2009 £2,105
Point of Care Diagnostic Testing World Markets
Jun 2009 £2,050
Brazil Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2015
Jun 2009 £1,545
China Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2015
Jun 2009 £1,545
Global Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2015
Jun 2009 £2,475
The Top 100 Point-Of-Care Manufacturing Companies Worldwide
Second Edition
May 2009 £630
Strategic Analysis of the European Markets for Theranostics
May 2009 £3,965
Cystic Fibrosis, Mucoviscoidosis NA Tests in UK
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Chlamydia trachomatis/Neisseria gonorrheae (CT/NG) NA Tests in UK
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
RSV NA Tests in Germany
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
VRE NA Tests in Germany
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Warfarin sensitivity (CYP2C9, VKOR1) NA Tests in Spain
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Adenovirus NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Neisseria Gonorrheae (NG) NA Tests in Germany
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Parainfluenza 1, 2, 3 NA Tests in Germany
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Mycobacterium Tuberculosis Direct (MTD) NA Tests in Spain
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
VZV NA Tests in Germany
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Warfarin sensitivity (CYP2C9, VKOR1) NA Tests in Germany
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Staphylococcus aureus NA Tests in Germany
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Clostridium Difficile (C.diff) NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Influenca A/B NA Tests in Spain
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Human Metapneumovirus (hMPV) NA Tests in Spain
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
CMV Quant NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
BK Virus NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Parainfluenza 1, 2, 3 NA Tests in Spain
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Chlamydia Trachomatis (CT) NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Group B Streptococcus (GBS) NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Staphylococcus aureus NA Tests in Spain
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Fragile X NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HIV Qualitative NA Tests in Spain
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
CMF Viral Load NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HCV Viral Load NA Tests in Spain
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Enterovirus NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
RSV NA Tests in UK
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
CMV Quant NA Tests in UK
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
CMF Viral Load NA Tests in UK
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Factor V Leiden NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Factor V Leiden NA Tests in Spain
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Chlamydia trachomatis/Neisseria gonorrheae (CT/NG) NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HBV Ressistance NA Tests in Spain
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Factor II NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Chlamydia Trachomatis (CT) NA Tests in UK
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HIV Viral Load NA Tests in UK
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Cystic Fibrosis, Mucoviscoidosis NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Human Metapneumovirus (hMPV) NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HCV Genotyping NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HBV Viral Load NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Chlamydia trachomatis/Neisseria gonorrheae (CT/NG) NA Tests in Spain
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Adenovirus NA Tests in Spain
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HCV Qualitative NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Mycobacterium Tuberculosis Direct (MTD) NA Tests in Italy
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Her2Neu NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HBV Quantitative NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Staphylococcus aureus NA Tests in Italy
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HCV Viral Load NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HCV Qualitative NA Tests in Spain
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HIV Viral Load NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Epstein-Barr Virus (EBV) NA Tests in Spain
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Enterovirus NA Tests in Spain
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Cystic Fibrosis, Mucoviscoidosis NA Tests in Spain
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Warfarin sensitivity (CYP2C9, VKOR1) NA Tests in Italy
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HBV Ressistance NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HIV Qualitative NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HCV Viral Load NA Tests in Italy
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Human Metapneumovirus (hMPV) NA Tests in Italy
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HLA Typing NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HPV Quantitative NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HPV Genotyping NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HIV Genotyping NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HIV Qualitative NA Tests in Italy
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Neisseria Gonorrheae (NG) NA Tests in Italy
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Influenca A/B NA Tests in Italy
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Parainfluenza 1, 2, 3 NA Tests in Italy
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
MRSA NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HCV Qualitative NA Tests in Italy
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
MAC NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HSV 2 NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Influenca A/B NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HSV 1 NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
HPV Quantitative NA Tests in Italy
Assessment of the Molecular Diagnostic Market
Apr 2009 £360
Group A Streptococcus (GAS) NA Tests in France
Assessment of the Molecular Diagnostic Market
Apr 2009 £360

Industry Events

2nd International Conference on Drug Discovery and Therapy

01 Feb 10 to 04 Feb 10
Dubai, United Arab Emirates
view summary >>

Oncology Market & Patient Access

14 Dec 09 to 16 Dec 09
Prague, Czech Republic
view summary >>

Orphan & Ultra Orphan Drugs

13 Jan 10 to 14 Jan 10
Brussels, Belgium
view summary >>